sub_header-1024x120

Featured Product: Moveox

For the clinical dietary management of osteoarthritis.

Untitled 2
box_partner
Untitled 1

NEWS

BMG Pharma: GelX® approved in Europe for prevention of oral mucositis in cancer patients.

BMG Pharma: GelX® approved in Europe for prevention of oral mucositis in cancer patients.

May 14, 2018 Milan, Italy: BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the European regulatory
Read More
BMG Pharma S.r.l Announces the Launch of Its AFTACURE Gel and AFTACURE Spray under the ELGYDIUM CLINIC Brand as Cicalium Gel and Cicalium Spray by its Partner Pierre Fabre Medicament in France

BMG Pharma S.r.l Announces the Launch of Its AFTACURE Gel and AFTACURE Spray under the ELGYDIUM CLINIC Brand as Cicalium Gel and Cicalium Spray by its Partner Pierre Fabre Medicament in France

February 27 2018. MILAN, Italy & CASTRES, France. BMG Pharma S.r.l., an Italian specialty pharmaceutical company is pleased to announce that
Read More
BMG Pharma is pleased to announce positive clinical results on gelx® the first breakthrough product to achieve prevention of oral mucositis in cancer patients.

BMG Pharma is pleased to announce positive clinical results on gelx® the first breakthrough product to achieve prevention of oral mucositis in cancer patients.

November 16 2017 Milan, Italy: BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the first efficacy
Read More

KNOW MORE ABOUT US AND OUR PRODUCTS